Zevra - ADHS - A Star is born (Seite 4)
eröffnet am 06.09.21 11:06:47 von
neuester Beitrag 03.06.24 18:30:47 von
neuester Beitrag 03.06.24 18:30:47 von
Beiträge: 42
ID: 1.352.190
ID: 1.352.190
Aufrufe heute: 5
Gesamt: 4.296
Gesamt: 4.296
Aktive User: 0
ISIN: US4884452065 · WKN: A2QLX7 · Symbol: 1GDA
4,3600
EUR
-4,80 %
-0,2200 EUR
Letzter Kurs 14.06.24 Tradegate
Neuigkeiten
| TitelBeiträge |
|---|
03.06.24 · globenewswire  |
09.05.24 · globenewswire |
08.05.24 · globenewswire |
01.05.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,8000 | +2.566,67 | |
| 3,3000 | +44,74 | |
| 1,2200 | +31,76 | |
| 1,2450 | +29,69 | |
| 7,7600 | +29,33 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,7900 | -24,80 | |
| 1,0100 | -26,81 | |
| 9,5300 | -34,00 | |
| 1,0200 | -34,19 | |
| 1,2400 | -34,39 |
Beitrag zu dieser Diskussion schreiben
Feedback
Es wird spannend in 2022 
Unser ADHS Medikament jetzt auch für den chinesischen Markt
Leider wird KemPharm nicht erwähnt, aber so ist das halt wenn ein Produkt zum Vertrieb auslizensiert wurde, aber das schälert die News keinesfalls. Sollte die Tage auch noch was Offizielles von KemPharm dazu kommen
Ark Biopharmaceutical Enters Into Exclusive License Agreement for Novel ADHD Treatment Azstarys® in Greater China
December 28, 2021 19:00 ET | Source: Shanghai Ark Biopharmaceutical Co., Ltd.
AZSTARYS, approved and commercialized by Corium, Inc. in the U.S., is an innovative treatment for ADHD patients ages 6 years and older providing rapid and extended duration symptom control as the First and Only Product containing Prodrug of Dexmethylphenidate
Agreement provides up to a total of $105.5 million USD in upfront, developmental and sales milestone payments, as well as royalties on product net sales
https://www.globenewswire.com/news-release/2021/12/29/235861…
Unser ADHS Medikament jetzt auch für den chinesischen Markt
Leider wird KemPharm nicht erwähnt, aber so ist das halt wenn ein Produkt zum Vertrieb auslizensiert wurde, aber das schälert die News keinesfalls. Sollte die Tage auch noch was Offizielles von KemPharm dazu kommen
Ark Biopharmaceutical Enters Into Exclusive License Agreement for Novel ADHD Treatment Azstarys® in Greater China
December 28, 2021 19:00 ET | Source: Shanghai Ark Biopharmaceutical Co., Ltd.
AZSTARYS, approved and commercialized by Corium, Inc. in the U.S., is an innovative treatment for ADHD patients ages 6 years and older providing rapid and extended duration symptom control as the First and Only Product containing Prodrug of Dexmethylphenidate
Agreement provides up to a total of $105.5 million USD in upfront, developmental and sales milestone payments, as well as royalties on product net sales
https://www.globenewswire.com/news-release/2021/12/29/235861…
KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program
Mon, December 20, 2021,
CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its Board of Directors has authorized a program to repurchase up to $50 million of the Company’s outstanding stock. The share repurchase authorization is effective immediately and valid through December 31, 2023. This program is equivalent to approximately 18 percent of KemPharm’s current market capitalization.
KemPharm: Who We Are
Congrats to @KemPharmInc on winning the #BioFL2021 Company of the Year award! KemPharm has received FDA approval on a truly differentiating ADHD drug. We look forward to continuing to see this company’s success as they develop new and innovative treatments.
https://twitter.com/BioFlorida/status/1469304159539245060
https://twitter.com/BioFlorida/status/1469304159539245060
Aufrufe heute: 0 
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
Wed, November 10, 2021, 10:05 PM
Corporate and Regulatory Highlights
Appointment of Richard W. Pascoe as Executive Chairman; Mr. Pascoe to focus on executing the Company’s strategic growth plans
Uplisted to The Nasdaq Global Select Market
Research involving AZSTARYS® and serdexmethylphenidate featured in poster presentations at multiple medical conferences during ADHD Awareness Month (October)
Data presented during the 2021 Virtual International Conference on ADHD affirmed AZSTARYS’ 30-minute onset of action and 13-hour duration of effect
Appointed Tamara A. Seymour to Board of Directors
U.S. commercial launch of AZSTARYS initiated on July 21, 2021
Financial Highlights
Q3 2021 net loss of $0.05 per basic share
Reported Q3 2021 revenue of $2.0 million
Total cash and cash equivalents was $131.5 million at September 30, 2021
https://finance.yahoo.com/news/kempharm-reports-third-quarte…
KemPharm Reports Third Quarter 2021 Financial Results and Corporate Updates
Wed, November 10, 2021, 10:05 PM
Corporate and Regulatory Highlights
Appointment of Richard W. Pascoe as Executive Chairman; Mr. Pascoe to focus on executing the Company’s strategic growth plans
Uplisted to The Nasdaq Global Select Market
Research involving AZSTARYS® and serdexmethylphenidate featured in poster presentations at multiple medical conferences during ADHD Awareness Month (October)
Data presented during the 2021 Virtual International Conference on ADHD affirmed AZSTARYS’ 30-minute onset of action and 13-hour duration of effect
Appointed Tamara A. Seymour to Board of Directors
U.S. commercial launch of AZSTARYS initiated on July 21, 2021
Financial Highlights
Q3 2021 net loss of $0.05 per basic share
Reported Q3 2021 revenue of $2.0 million
Total cash and cash equivalents was $131.5 million at September 30, 2021
https://finance.yahoo.com/news/kempharm-reports-third-quarte…
Trading Spotlight
Sehr gute Erfahrungsberichte der ersten Anwender - freut mich auch und insbesondere für die betroffenen Kinder, Eltern und Lehrer. Azstarys works
"Yes, not really seeing any negatives yet. Her teacher made a comment to mom today, that she was very attentive today. She had no knowledge of her treatment. I also notice more communication w me and mom verbally and visually. Its been wonderful. Im still trying not to get to excited though. Fingers crossed"
"My son took his first dose today. As I was dropping him off to school today, he said, “Dad, I’m really excited for school today.” Already a winner in my book."
"So my daughter is also Autistic (luckily very mild ASD)
Day 2 her appetite is great. Definite improvement from what the norm was. I am amazed at how much attention she has while doing homework or even watching cartoons. We just did not see these things with other treatments. Awesome".
https://stocktwits.com/alanls1/message/387141793
"Yes, not really seeing any negatives yet. Her teacher made a comment to mom today, that she was very attentive today. She had no knowledge of her treatment. I also notice more communication w me and mom verbally and visually. Its been wonderful. Im still trying not to get to excited though. Fingers crossed"
"My son took his first dose today. As I was dropping him off to school today, he said, “Dad, I’m really excited for school today.” Already a winner in my book."
"So my daughter is also Autistic (luckily very mild ASD)
Day 2 her appetite is great. Definite improvement from what the norm was. I am amazed at how much attention she has while doing homework or even watching cartoons. We just did not see these things with other treatments. Awesome".
https://stocktwits.com/alanls1/message/387141793
Antwort auf Beitrag Nr.: 69.439.360 von flyingbeef am 27.09.21 23:31:59
So schauts aus
Gerne auch ein paar Dollar in prominente Markenbotschafter investieren, da gibts etliche mit ADHS von denen man es nicht gedacht hätte. Wusste es nur von Bubba Watson.
War für mich eigentlich immer so eine Vorschul/ Grundschul Geschichte, eh ich mich näher mit KemPharm beschäftigt hatte
Famous People with ADHD
https://addadult.com/add-education-center/famous-people-with…
Zitat von flyingbeef: Corium erhält Finanzspritze für Vermarktung, News Heute sollte einiges an Zuversicht bringen das alle Beteiligten es ernst meinen und bald auch etwas mehr Speed bei Vermarktung aufgenommen werden kann.
So schauts aus
Gerne auch ein paar Dollar in prominente Markenbotschafter investieren, da gibts etliche mit ADHS von denen man es nicht gedacht hätte. Wusste es nur von Bubba Watson.
War für mich eigentlich immer so eine Vorschul/ Grundschul Geschichte, eh ich mich näher mit KemPharm beschäftigt hatte
Famous People with ADHD
https://addadult.com/add-education-center/famous-people-with…
Corium erhält Finanzspritze für Vermarktung, News Heute sollte einiges an Zuversicht bringen das alle Beteiligten es ernst meinen und bald auch etwas mehr Speed bei Vermarktung aufgenommen werden kann.
Antwort auf Beitrag Nr.: 69.411.392 von soulist am 23.09.21 21:34:35"Message to shareholders: ALL UPSIDE FROM HERE"
Travis Mickle, CEO KemPharm Answers ALL Viewer Questions On $KMPH Company and the Future! 23.09.2021
The Clinical Research Circle
The Clinical Research Circle
Durchsuchen
Zevra - ADHS - A Star is born
